LogoFDA 510(k) Search
Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K122561
    Device Name
    ADAPTAIN FASTWRAP, ENVELOCK, GRAFTAIN
    Manufacturer
    CEREMED, INC.
    Date Cleared
    2012-11-27

    (97 days)

    Product Code
    KHJ,PRE
    Regulation Number
    874.3620
    Type
    Traditional
    Panel
    Ear Nose & Throat
    Reference & Predicate Devices
    K120220
    Why did this record match?
    Device Name :

    ADAPTAIN FASTWRAP, ENVELOCK, GRAFTAIN

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Adaptain FastWrap™ is indicated for use as a water-soluble implant material and as a water-soluble space occupying material as an adjunct during the natural healing process.

    Device Description

    Adaptain FastWrap™ is an odorless, opaque wax-like material designed to be utilized directly out of the package. It is best used immediately following removal from the package, and can be softened and increased in stickiness by warming and by additional . handling and manipulation, if so desired. Adaptain FastWrap "" is comprised of a sterile mixture of water-soluble alkylene oxide copolymers (AOC PolymerBlend"). Adaptain FastWrap " contains no other additives or colorants. Adaptain FastWrap™ is formed in bars and sheets of various sizes with weights ranging from 0.5 to 5 grams each. Adaptain FastWrap is provided sterile by irradiation and must not be resterilized.

    AI/ML Overview

    The provided text describes a 510(k) submission for the Adaptain FastWrap™ and Envelock™ devices. However, it does not contain any information about acceptance criteria, device performance, a study to prove acceptance criteria, sample sizes, data provenance, expert ground truth establishment, adjudication methods, MRMC studies, or standalone algorithm performance.

    The document primarily focuses on the administrative aspects of the 510(k) submission, including:

    • Identification of the submitting company and contact person.
    • Device names, regulation numbers, regulatory class, and product codes.
    • Description of the device's composition and form.
    • Intended use and indications for use.
    • A declaration of substantial equivalence to a predicate device (Ceremed, Inc. Ceretene™ Soluble Implant Material (K120220)).
    • Formal FDA correspondence confirming the substantial equivalence determination.

    The statement regarding "non-clinical evaluations used to determine substantial equivalence included indications, intended use, design, materials, sterilization, and performance" is a general declaration, but no specific data, metrics, or study details are provided to support this. Therefore, I cannot construct the table or answer the specific questions based on the provided text.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1